Skip to main content
ArticleOPEN ACCESS

A new face of BCL-2 inhibition in CLL

Blood
DOI: 10.1182/blood-2011-01-328658
2Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Zhong and colleagues report on a peptide that is selectively toxic to chronic lymphocytic leukemia (CLL) cells through perturbation of cytoplasmic calcium levels via disruption of the BCL-2:IP3R interaction.

Cite

CITATION STYLE

APA

Letai, A. (2011, March 10). A new face of BCL-2 inhibition in CLL. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2011-01-328658

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free